Home500257 • BOM
add
Lupin Ltd
Nakaraang pagsara
₹2,028.90
Sakop ng araw
₹2,000.10 - ₹2,081.95
Sakop ng taon
₹1,493.75 - ₹2,403.45
Market cap
912.88B INR
Average na Volume
18.15K
P/E ratio
31.91
Dividend yield
0.40%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 57.68B | 10.97% |
Gastos sa pagpapatakbo | 28.66B | 5.90% |
Net na kita | 8.55B | 39.48% |
Net profit margin | 14.83 | 25.68% |
Kita sa bawat share | 18.69 | 39.37% |
EBITDA | 13.93B | 47.39% |
Aktuwal na % ng binabayarang buwis | 19.83% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 29.12B | 68.06% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 157.20B | — |
Natitirang share | 456.09M | — |
Presyo para makapag-book | 5.91 | — |
Return on assets | — | — |
Return on capital | 15.39% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 8.55B | 39.48% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Itinatag
1968
Headquarters
Website
Mga Empleyado
19,210
